|
2021–2029 |
Undergraduate Program Medical studies in English |
|
2017–2022 |
Support of surveillance activities of human influenza in Europe 2017-2021 - Training. |
|
2014–2015 |
Solid self - emulsifying pharmaceutical dosage forms for the improvement of the absorption of poorly water soluble dugs |
|
2005–2009 |
Development of multipleunit system (micro-pellets-microtablets) forternary drug release (stomach-intensine-colon) |
|
2005–2007 |
PYTHAGORAS II |
|
2004–2007 |
Characterization of solid pharmaceyticals and improvement of therapeutic efficacy by advanced analytic techniques and crystal engineering |
|
2001–2002 |
Bovine spongiform encephalopathy (BSE) :surveillance in cattle by use of rapid immunological diagnostic tests. |
|
2001–2004 |
Phylogenetic analysis and improved diagnostic assay systems for viruses of the family Reoviridae |
|
1999–2002 |
The establishment of a European network for the surveillance of ruminant TSE and the standardisation and harmonisation of the process and criteria for the identificaion of suspected cases. |
|
1999–2002 |
Molecular characterisation and epidemiology of encephalomyocarditis virus: a model for emerging diseases |
|
1998–2001 |
Prion Diseases. Mechanism of transmission and identification of targets for potential therapentics. |
|
1998–2000 |
CJI and BSE: An intigrated molecular and experimental neuropathological analysis of prion neurodegeneration, strain variation and transmission risks. |
|
1998–2002 |
Improving prospects for scrapie control in sheep and goats by study of host genotypes, TSE isolates and their in-vivo and in-vitro interactions |
|
1996–1999 |
The study of prion propagation, pathogenesiw and intermmalian species barriers in transgenic and other models of prion disease. |
|
1996–1998 |
Ο ρόλος των υδατανθράκων στην παθογένεση και παθοφυσιολογία των νευρεκφυλιστικών ασθενειών. |
|
1994–1998 |
Charracterization of the Bivine Spongiform Encephalopathy (BSE) infectious agent. |
